Straumann's Financial Report Reveals: Asia-Pacific Market Grows by 19.7%, while North American Market Grows Only by 2%!

Straumann (STMN.S), one of Switzerland's leading dental implant makers, reported impressive results on Tuesday. The report shows that the company delivered significant organic revenue growth in the third quarter, with double-digit growth rates, as more people globally, especially in the Asia-Pacific region, began to value and seek high-quality dental services.

For the quarter, Strommann reported total revenue of 585.5 million Swiss francs ($676.6 million), an 11.2 percent increase after excluding the impact of currency fluctuations and acquisitions. This result fully demonstrates the company's strong competitiveness and continuous growth momentum in the global dental implant market.

Straumann has done particularly well in the Asia-Pacific market. The region already accounts for about a quarter of the company's sales, and its organic growth rate of 19.7 percent was the fastest of any region. This result was mainly due to the strong performance of the company's plantation business. Countries such as Thailand, India, and Malaysia made particularly prominent market contributions, registering double-digit growth. It is important to note that this figure does not include China, a fast-growing market.

Meanwhile, the Europe, Middle East, and Africa (EMEA) region also recorded an 11.4 percent increase in revenue. The region is Straummann's largest market, accounting for 37 percent of the company's total sales. Despite some challenges, the company's solid performance in this region is still impressive.

In North America, however, Straumann's sales grew by a relatively low 2 percent. The slow growth in North America, which accounted for 27.8% of the company's total sales, was mainly due to slowing patient mobility and a weak implant market. Still, CEO Guillaume Daniellot said in the earnings release, "Our commitment to our customers and the dedication of our team once again helped us deliver strong growth."

Strauman AG is confident about its future growth prospects and has confirmed its guidance for organic revenue growth for the full year. According to company projections, this growth rate will remain in the low double-digit percentage range. Further, based on constant currency exchange rates in 2023, the company expects a full-year margin of 27-28% of sales. This guidance figure once again demonstrates Strauman's leading position and continued growth potential in the global dental implants market.